How do I buy SI-BONE, Inc. Common Stock (SIBN) stock?

Buying SI-BONE, Inc. Common Stock (SIBN) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and verify your identity. Make a deposit. Search for the code "SIBN", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy SIBN by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

What is the minimum investment for SIBN on Gotrade?

On Gotrade , you don't have to buy a full share. With fractional shares, you can start investing in SI-BONE, Inc. Common Stock from just $1. A small budget shouldn't stop you from building a US stock portfolio.

Does SI-BONE, Inc. Common Stock (SIBN) pay dividends?

At the moment, SI-BONE, Inc. Common Stock (SIBN) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track SIBN's performance via the price chart in the Gotrade app.

Is buying SIBN on Gotrade safe and legal?

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

What are the market hours to buy SIBN?

You can place an order any time. It goes through when the US market (NYSE/NASDAQ) opens: 9:30 AM to 4:00 PM New York time, Monday to Friday. Pre-market and after-hours trading are open too. The market is closed on US public holidays. The Gotrade app shows whether the market is open.

How do I tell if SIBN is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

SI-BONE, Inc. Common Stock (SIBN) Stock Price: Nov 11 Close $24.94

News tone: automated (AI) classification of the article's content, not a price prediction.

About SI-BONE, Inc. Common Stock

SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

SectorHealthcare

IndustryMedical Devices

Employees376

CEOMs. Laura A. Francis MBA

IPO DateOct 17, 2018

HeadquartersSanta Clara, CA

Key Executives

Name	Title	Year Born
Ms. Laura A. Francis MBA	CEO & Director	1967
Mr. Jeffrey W. Dunn	Executive Chairman	1956
Mr. Anshul Maheshwari	COO & CFO	1980
Mr. Michael A. Pisetsky J.D.	Chief Business & Legal Affairs Officer, Secretary and General Counsel	—
Mr. Anthony J. Recupero	Advisor	1960
Dr. Scott A. Yerby Ph.D.	Senior VP of Engineering & CTO	1968
Mr. Saqib Iqbal	Vice President of Financial Planning & Analysis and Investor Relations	—
Mr. Ian Bailey	Vice President of Product & Marketing	—
Dr. Daniel Joseph Cher M.D.	Senior Vice President of Clinical, Regulatory Affairs & Quality	1965
Dr. W. Carlton Reckling M.D.	Chief Medical Officer & VP of Medical Affairs	1963

Fundamentals

Valuation

Price-to-sales ratio6.41

Price-to-book value6.13

Profitability

Return on Equity-8.00%

Return on Assets-6.00%

Return on Sales-5.00%

Gross margin (latest quarter)79.29%

EBITDA$-4.63M

Trading

Average volume907,779

Source: third-party data provider, as of November 13, 2026

Technical indicators

RSI 14: 66.53
MACD 12/26/9: 1.45
EMA 9 of MACD: 1.15
MACD histogram: 0.30
SMA 50: $20.18; Price above SMA 50
EMA 50: $20.85; Price above EMA 50
SMA 200: $16.68; Price above SMA 200
EMA 200: $17.99; Price above EMA 200

Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.

Analyst views

4 analyst ratings

Third-party analyst opinion, not a recommendation from Gotrade.

Analyst consensus:Buy

100% Buy

0% Hold

0% Sell

Analyst price target

Low: $23.00
Average: $25.00
High: $26.00

Truist Securities

Richard Newitter

Buy

Target price

$25.00

Needham

David Saxon

Buy

Target price

$26.00

TD Cowen

Mathew Blackman

Buy

Target price

$23.00

UBS

Patrick Wood

Buy

Target price

$26.00

Seasonality

Monthly price change (%)

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2021											-10.7	+18.5
2022	-13.5	+11.4	+3.5	-12.1	-26.4	-9.2	-1.2	+20.2	+5.2	+11.5	-34.3	+7.3
2023	+27.9	+16.0	-1.7	+14.0	+11.4	+6.9	-5.6	-10.9	-6.1	-19.7	+9.8	+11.5
2024	-3.0	-15.9	-4.2	-9.6	-3.2	-9.5	+17.8	+12.0	-12.3	+1.3	+0.5	+4.9
2025	+20.3	+6.5	-20.1	-2.8	+38.2	-0.2	-7.0	-4.1	-10.5	+3.9	+29.3	+4.5
2026	-16.2	-5.2	-19.6	-4.8	+6.7	+17.7	+5.7	+3.1	-0.6	+15.3	+23.3

Earnings per share

$-0.31

-

SI-BONE, Inc. Common Stock (SIBN) Stock

Key stats

Compare with SIBN

Recent news

SI-Bone Reports Q3 2026 Revenue of $55.7 Million, Up 14.5%

SI-Bone Reports Q3 2026 Revenue of $55.7 Million, Up 14.5%

SiBone Q3 Earnings Call Highlights

SiBone Q3 Earnings Call Highlights

Si-Bone (SIBN) Reports Q3 Loss, Tops Revenue Estimates

Si-Bone (SIBN) Reports Q3 Loss, Tops Revenue Estimates

Si-Bone (SIBN) is a Great Momentum Stock: Should You Buy?

Si-Bone (SIBN) is a Great Momentum Stock: Should You Buy?

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

SI-Bone Reports Q3 2026 Revenue of $55.7 Million, Up 14.5%

SI-Bone Reports Q3 2026 Revenue of $55.7 Million, Up 14.5%

SiBone Q3 Earnings Call Highlights

SiBone Q3 Earnings Call Highlights

Si-Bone (SIBN) Reports Q3 Loss, Tops Revenue Estimates

Si-Bone (SIBN) Reports Q3 Loss, Tops Revenue Estimates

Si-Bone (SIBN) is a Great Momentum Stock: Should You Buy?

Si-Bone (SIBN) is a Great Momentum Stock: Should You Buy?

Wall Street Analysts Believe Si-Bone (SIBN) Could Rally 25.25%: Here's is How to Trade

Wall Street Analysts Believe Si-Bone (SIBN) Could Rally 25.25%: Here's is How to Trade

Does Si-Bone (SIBN) Have the Potential to Rally 38.58% as Wall Street Analysts Expect?

Does Si-Bone (SIBN) Have the Potential to Rally 38.58% as Wall Street Analysts Expect?

Si-Bone (SIBN) Reports Q2 Loss, Tops Revenue Estimates

Si-Bone (SIBN) Reports Q2 Loss, Tops Revenue Estimates

SiBone Q2 Earnings Call Highlights

SiBone Q2 Earnings Call Highlights

Bears are Losing Control Over Si-Bone (SIBN), Here's Why It's a 'Buy' Now

Bears are Losing Control Over Si-Bone (SIBN), Here's Why It's a 'Buy' Now

Wall Street Analysts Predict a 71.13% Upside in Si-Bone (SIBN): Here's What You Should Know

Wall Street Analysts Predict a 71.13% Upside in Si-Bone (SIBN): Here's What You Should Know

About SI-BONE, Inc. Common Stock

Key Executives

Fundamentals

Valuation

Profitability

Trading

Technical indicators

Analyst views

Seasonality

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

Stocks in the same sector

FAQ

Trade Faster. Easier. Smarter.

#ReadyGoTrade